--- title: "Pre-market hot trades in US stocks: Peraso pre-market down 28.25%; CEL-SCI pre-market down 26.95%" type: "News" locale: "en" url: "https://longbridge.com/en/news/286058102.md" description: "Peraso pre-market down 28.25%; CEL-SCI pre-market down 26.95%; BuzzFeed pre-market up 110.78%; Haoxi Health Tech pre-market up 49.78%; Anbo Education pre-market up 39.79%" datetime: "2026-05-12T08:07:46.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286058102.md) - [en](https://longbridge.com/en/news/286058102.md) - [zh-HK](https://longbridge.com/zh-HK/news/286058102.md) --- # Pre-market hot trades in US stocks: Peraso pre-market down 28.25%; CEL-SCI pre-market down 26.95% **Pre-market Hot Trades in US Stocks** Peraso is down 28.25% in pre-market trading. Based on recent key news: 1. On May 11, Peraso announced its first-quarter financial report, with revenue of $1 million, a net loss of $2.5 million, and adjusted EBITDA of -$2.3 million. The report indicated that the company is facing financial pressure, leading to a significant drop in stock price. Source: Reuters 2. On May 11, Peraso announced the expansion of its 60 GHz wireless product deployment in urban and military markets, including the launch of the next-generation nRay. Despite significant technological advancements, weak market demand has affected short-term performance. Source: Peraso Inc. 3. On May 11, Peraso stated that supply chain issues have been resolved, and it expects a slight improvement in second-quarter revenue to $1.2 million. However, demand weakness caused by memory shortages continues to pressure the company's performance. Source: Peraso Inc. The technology industry is facing supply chain challenges, with increased market volatility. CEL-SCI is down 26.95% in pre-market trading. Based on recent key news: 1. On May 12, CEL-SCI announced a public offering at a price of $1.20 per share, issuing 6 million shares of common stock, with expected total proceeds of approximately $7.2 million. This move led to a drop in stock price of about 10% in pre-market trading. Source: Business Wire 2. On May 11, CEL-SCI reached a strategic agreement with Amarox to register, commercialize, and distribute Multikine in Saudi Arabia, signing a 50%/50% revenue sharing agreement. This news had a limited impact on the stock price. Source: Reuters 3. On May 12, CEL-SCI's Multikine has not yet received FDA or other regulatory approvals, and its safety and efficacy have not been established. This information may affect investor confidence. Source: Business Wire The biotechnology industry has been experiencing significant volatility recently, requiring attention. **Top Gainers in Pre-market US Stocks** BuzzFeed is up 110.78% in pre-market trading. Based on recent key news: 1. On May 12, BuzzFeed announced that Byron Allen will acquire a majority stake in the company for $120 million, with Allen becoming the CEO and Chairman. This news significantly boosted the stock price. Source: Viewpoint 2. On May 11, BuzzFeed stated that it failed to repay $5 million in debt on time, extending the deadline to May 18. This financial predicament has drawn market attention. Source: MarketWatch 3. On May 12, BuzzFeed reported that its net loss for the first quarter widened to $15.1 million, with revenue declining by 12.4% year-on-year. Poor financial performance has heightened market concerns. Source: Sina Finance The digital media industry is facing challenges, with tight liquidity Haoxi Health Tech pre-market rose 49.78%. Based on recent key news: 4. On May 11, Haoxi Health Technology announced a $6.5 million registered direct offering. The company reached a final agreement with investors to issue 9 million shares of Class A common stock and nearly 17 million pre-funded warrants, with each security priced at $0.25. This offering is expected to be completed on May 12, with the stock price rising 3.11%. 5. On May 11, Haoxi Health Technology released an announcement detailing the $6.5 million registered direct offering. The company plans to use the raised funds for working capital and general corporate purposes. 6. On May 11, Haoxi Health Technology's stock fell after the announcement of the $6.5 million registered direct offering. Recent capital inflows have been significant, and the overall industry has performed well. Anbo Education pre-market rose 39.79%. Based on recent key news: 1. On May 11, Anbo Education released its latest financial report, showing significant growth in the company's performance. The report indicated that Anbo Education's revenue increased by 50% year-on-year, and net profit grew by 30%, which boosted investor confidence in the company's future development and led to a substantial rise in stock price. 2. On May 10, Anbo Education announced a strategic cooperation agreement with a well-known education technology company. This collaboration will help Anbo Education expand its online education business, enhance market competitiveness, and further strengthen investor confidence, resulting in a rise in stock price. 3. On May 9, analysts upgraded Anbo Education's rating, believing that the company's leading position in the education industry and its continued growth potential are worth attention. Analysts expect the company's performance to continue strong growth in the coming quarters, and this optimistic outlook has driven the stock price up. The overall education industry has performed well, supported by policies ### Related Stocks - [PRSO.US](https://longbridge.com/en/quote/PRSO.US.md) - [CVM.US](https://longbridge.com/en/quote/CVM.US.md) - [BZFD.US](https://longbridge.com/en/quote/BZFD.US.md) - [HAO.US](https://longbridge.com/en/quote/HAO.US.md) - [AMBO.US](https://longbridge.com/en/quote/AMBO.US.md) ## Related News & Research - [Peraso Expands At-The-Market Equity Offering Capacity](https://longbridge.com/en/news/286477868.md) - [Cel-Sci Forms Multikine Commercialization Partnership in Middle East](https://longbridge.com/en/news/286482219.md) - [CEL-SCI Raises $7.2 Million in Stock Offering; Placement Agreement With ThinkEquity](https://longbridge.com/en/news/286316681.md) - [Peraso Q1 revenue falls 74% on delayed customer order](https://longbridge.com/en/news/285993228.md) - [Are Wall Street Analysts Bullish on Akamai Technologies Stock?](https://longbridge.com/en/news/286949319.md)